On September 26, Be The Match hosted their first Virtual Gala to promote and celebrate their mission, which is to save lives through bone marrow transplantation
Thermo Fisher Scientific’s global team partnered with One Legacy to support the annual Donate Life Run/Walk.
Through the creation of transplant patient education programs, Dr. Waterman's team is determined to end the organ shortage crisis.
This past December, ten volunteers joined hundreds of donor family members, transplant recipients, and transplant professionals in the effort to decorate the Donate Life Rose Parade float.
As a heart and kidney recipient, Regina Armstrong demonstrates both the life-saving power of transplantation and the need for further patient care innovations.
Here you’ll find the latest news and resources on how COVID-19 may impact the field of transplantation and may transform our understanding of both genotyping and antibody detection.
IWD is important not only for women on our team but also for the many women in STEM who face challenges in their career paths, for women advocates who serve the patient community, and for female transplant patients in need of better care.
The One Lambda team assembled care packages for dialysis patients with handwritten notes of encouragement for each patient.
Our very own Louise Lerminaux and friend Conna Jones chatted with #ScienceWithATwist about their journey as a donor & recipient pair and how organ donation has changed both their lives.
The TypeStream Visual NGS Analysis Software v2.0.1 update encompasses enhancements and the correction of known minor defects, and is designed to be the most robust version of TypeStream Visual software to-date.
With multiple distinct antigens and fragments, the LABScreen COVID Plus assay is more specific than current assays and, in combination with HLA antibody detection, can help provide a more complete picture of the patient’s antibody profile.
Results in 90 minutes, just 10 minutes hands-on time. No chips, gels, SNP reaction tables or proprietary instruments.
Testing for autoantibodies has never been more important as recent studies suggest a potential, long-term detrimental impact. The LABScreen Autoantibody assays allow you to characterize and monitor a broad range of autoantibody targets in human sera.
These software updates offer new functionality, feature enhancements, and correct known minor issues.
SureTyper Blood v1.3 is now available to analyze LinkSēq™ RBC, ABO and HPA kits. See new features
Our AllType™ and AllType™ FASTplex™ assays each offer a complete NGS solution that delivers high-resolution genotyping for all eleven Class I and Class II HLA loci.
LABScreen™ Single Antigen ExPlex offers the most expansive HLA Antibody test in a Single Well.
FlowDSA-XM™ simplifies the complexity of conventional crossmatch testing with clear results.
SureTyper 6.1 contains an enhanced Tray Viewer and Well Viewer interface that allows users to visualize the reactivity of our new multi-targeted assays! Whether one target is positive, both targets are positive, or the assay is negative, the updated Tray Viewer and Well Viewer in SureTyper 6.1 provides the user with visibility to the reactivity of this enhanced assay design.
Thermo Fisher Scientific continues to expand its response to the COVID-19 pandemic, developing a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2)
SAN CARLOS, Calif., Feb. 1, 2019 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of cell-free DNA, today announced a partnership with Thermo Fisher Scientific's One Lambda brand...
CANOGA PARK, Calif., May 16, 2017 (PRNewswire) -- One Lambda, a Thermo Fisher Scientific brand, announced today that it has signed an exclusive licensing agreement with Transcriptome Sciences Inc. (TSI) of Edmonton, Canada for its new microarray biopsy service, the Molecular Microscope™ Diagnostic System (MMDx).
Thermo Fisher Scientific Inc. and QIAGEN N.V. today announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher's proposal to acquire QIAGEN in cash.
SAN DIEGO, July 31, 2017 (PRNewswire) -- AACC -- Thermo Fisher Scientific today announced the successful CE-IVD registration of its QuantStudio 5 Dx Real-Time PCR System for sale in European countries.
CANOGA PARK, Calif. April 7, 2015 (BUSINESS WIRE) --One Lambda, Inc., part of Thermo Fisher Scientific and leading producer of in vitro diagnostic products for the HLA transplant community, today announced the availability of the only FDA cleared and CE marked assay for detecting HNA-3, as well as HLA...
Transplant Patient Stories
Each quarter we have transplant patient or donor families share their incredible stories with us.
Join Our Mailing List
Want to be informed about product updates and upcoming workshops?
Or, enroll via text message:
Text HLANEWS to 22828 to get started.
(•▿•)> ⇣ Scroll down to see more Tweets.
© Copyright 2015-2016 Thermo Fisher Scientific Inc. All Rights Reserved.